1.
|
Phase: Phase III Type: Tissue collection/Repository, Treatment Status: Active Age: 21 and under Sponsor: NCI, Other Protocol IDs: CDR0000654889, COG-AHEP0731, AHEP0731, NCT00980460
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 21 and under Sponsor: Other Protocol IDs: BMT 0499 Solid, NCT00179816
|
|
3.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 12 to 17 Sponsor: Pharmaceutical / Industry Protocol IDs: CLDE225X2104, 2010-019348-37, NCT01125800
|
|
4.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 2 to 20 Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: 100220, IND 59,056, NCT01222780
|
|
5.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 1 to 21 Sponsor: NCI, Other Protocol IDs: CDR0000680512, COG-ADVL0921, ADVL0921, NCT01154816
|
|
6.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 2 to 30 Sponsor: NCI Protocol IDs: NCI-2012-00106, ADVL1121, U10CA098543, CDR0000721611, COG-ADVL1121, NCT01502410
|
|
7.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 12 and over Sponsor: Other Protocol IDs: 11-211, NCT01642186
|
|
8.
|
Phase: Phase II Type: Treatment Status: Active Age: 0 to 40 Sponsor: Other Protocol IDs: J12106, NCT01804634
|
|
9.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 2 to 21 Sponsor: Other Protocol IDs: SorIrin1576, NCT01518413
|
|
10.
|
Phase: Phase I Type: Treatment Status: Active Age: 2 to 21 Sponsor: Other Protocol IDs: RADIANT, NCT01625351
|
|
11.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Over 18 Sponsor: NCI, Other Protocol IDs: CDR0000554417, JHOC-J0685, NA_00003073, J0685, NCT00499733
|
|
12.
|
Phase: No phase specified Type: Treatment Status: Active Age: 70 and under Sponsor: Other Protocol IDs: 2011OC057, MT2011-09C, NCT01505569
|